Holen Sie sich die Stockscreener-App
58.16
2.17%
-1.295
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten
Bristol-Myers Squibb Co stock (US1101221083): pharma heavyweight after Q1 2026 earnings and dividend - AD HOC NEWS
Bristol-Myers Squibb stock (US1078421011): oncology and immunology pipeline under investor scrutiny - AD HOC NEWS
Bristol-Myers Squibb Company stock (US0897961004): Pharma heavyweight navigates Revlimid cliff and w - AD HOC NEWS
Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 5.89% Upside Potential - DirectorsTalk Interviews
Bristol-Myers Squibb Company stock (US0897961004): cancer pipeline focus after Opdivo and Eliquis up - AD HOC NEWS
Is Bristol-Myers Squibb (BMY) One of the Best Dividend Stocks to Invest in According to Hedge Funds? - Insider Monkey
12 Best Dividend Stocks to Invest In According to Hedge Funds - Insider Monkey
Bristol Myers Squibb Company $BMY Position Trimmed by Associated Banc Corp - MarketBeat
How Bristol Myers Squibb’s Claude AI Deployment Across its Pipeline (BMY) Has Changed Its Investment Story - simplywall.st
Meiji Yasuda Asset Management Co Ltd. Purchases 55,355 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic Partnership - Insider Monkey
Bristol-Myers Squibb Company stock (US0897961004): Analyst moves and dividend draw fresh attention - AD HOC NEWS
BioNTech präsentiert auf der ASCO-Jahrestagung 2026 Fortschritte aus Pipelineprogrammen in der späten klinischen Entwicklung - GlobeNewswire Inc.
BMY Stock Price, Quote & Chart | BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - ChartMill
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline - BioSpace
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientif - pharmiweb.com
HALL CAPITAL MANAGEMENT CO INC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch
ETFs Investing in Bristol-Myers Squibb Company Stocks - TradingView
In Alzheimer’s, Bristol Myers sees big promise beyond amyloid - BioPharma Dive
Bristol Myers Squibb Partners With Anthropic to Deploy Claude Across Global Operations - Digital Health News
Why so many pharmaceutical giants want to invest billions in Houston - The Business Journals
BMS expands AI push with Anthropic partnership - The Pharma Letter
PNC Financial Services Group Inc. Sells 225,894 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Hengrui, BMS deal watershed moment for China biotech - BioWorld News
Biopharma Giant Bristol Myers Squibb Partners with Anthropic for AI Integration - GuruFocus
Anthropic And OpenAI--Building Different Competitive Advantages - Benzinga
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery - Benzinga
Bristol Myers deepens AI investment with Anthropic deal - BioPharma Dive
Anthropic signs enterprise AI deal with Bristol Myers Squibb - MobiHealthNews
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows - Fierce Pharma
Bristol Myers Squibb Expands AI Push With Anthropic’s Claude for 30,000 Employees - citybiz
Bristol Myers to deploy Anthropic’s Claude AI model to accelerate drug discovery - The News International
Exclusive | Bristol-Myers Squibb Brings Anthropic’s Claude to 30,000 of Its Staff - WSJ
Bristol-Myers Squibb (BMY) Gets a Hold from Scotiabank - The Globe and Mail
Bristol Myers to deploy Anthropic’s Claude AI model to speed up drug discovery By Reuters - Investing.com
Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery - Reuters
Bristol Myers Squibb partners with Anthropic to deploy Claude AI By Investing.com - Investing.com Canada
Bristol Myers, Anthropic to partner on Claude use - Breakingthenews.net
How Bristol Myers will use Anthropic’s Claude to speed medicines to patients - Stock Titan
BMY Technical Analysis | Trend, Signals & Chart Patterns | BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - ChartMill
TiNivo-2 Completion: What Bristol-Myers Squibb’s Kidney Cancer Trial Means for Investors - TipRanks
Bristol-Myers Squibb Company stock (US0897961004): oncology pipeline and US expansion keep the pharm - AD HOC NEWS
Pharma giant considers Houston for $1 billion manufacturing campus - InnovationMap
Resona Asset Management Co. Ltd. Sells 21,761 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law - Benzinga
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts - Yahoo Finance
Bristol Myers Squibb eyes $1B drug manufacturing campus in Generation Park - Community Impact | News
SCOTUS rejects Medicare drug price negotiation appeals by drugmakers - Modern Healthcare
Bristol-Myers Squibb Company stock (US0897961004): cancer drug news and pipeline focus after earning - AD HOC NEWS
Bristol-Myers Squibb Made Its Pipeline Case at BofA. Now Comes the Proof. - TIKR.com
BMY: Bristol Myers Squibb and Hengrui Pharma Strike $15.2B Licen - GuruFocus
Pharmaceutical giant eyes Houston for $1 billion campus - Chron
MCDONALD PARTNERS LLC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Vestcor Inc's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible - KHOU
Bristol Myers Squibb eyes Houston for $1B pharmaceutical plant - The Business Journals
Biopharma Collaboration: Bristol Myers Squibb Partners with Heng - GuruFocus
Bristol Myers Squibb touts pipeline gains as shareholders back board at annual meeting - MSN
Bristol Myers Squibb partners with Hengrui Pharma to develop and test drugs early in China. - Pluang
0.23%
4.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):